These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8169005)

  • 21. Second-messenger pathways involved in the regulation of survival in germinal-centre B cells and in Burkitt lymphoma lines.
    Knox KA; Finney M; Milner AE; Gregory CD; Wakelam MJ; Michell RH; Gordon J
    Int J Cancer; 1992 Dec; 52(6):959-66. PubMed ID: 1459737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p14ARF homozygous deletion or MDM2 overexpression in Burkitt lymphoma lines carrying wild type p53.
    Lindström MS; Klangby U; Wiman KG
    Oncogene; 2001 Apr; 20(17):2171-7. PubMed ID: 11360201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LY294002-mediated inhibition of phosphatidylinositol 3-kinase activity triggers growth inhibition and apoptosis in CD40-triggered Ramos-Burkitt lymphoma B cells.
    Curnock AP; Knox KA
    Cell Immunol; 1998 Aug; 187(2):77-87. PubMed ID: 9732695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced apoptotic cell clearance capacity and B cell survival factor production by IL-10-activated macrophages: implications for Burkitt's lymphoma.
    Ogden CA; Pound JD; Batth BK; Owens S; Johannessen I; Wood K; Gregory CD
    J Immunol; 2005 Mar; 174(5):3015-23. PubMed ID: 15728515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in Burkitt's lymphoma cell lines.
    Mouzakiti A; Packham G
    Br J Haematol; 2003 Jul; 122(1):61-9. PubMed ID: 12823346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of Epstein-Barr virus latent gene expression on the apoptosis-inducing effects of cortisone and 2-chlorodeoxyadenosine (2-CDA) in B-cell lines.
    Röth A; Pfaff P; Lange W; Finke J
    Cytokines Mol Ther; 1996 Mar; 2(1):21-8. PubMed ID: 9384686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of BCL-2 on survival and proliferation of human B-lymphoma cells following gamma-irradiation.
    Milner AE; Grand RJ; Vaughan AT; Armitage RJ; Gregory CD
    Oncogene; 1997 Oct; 15(15):1815-22. PubMed ID: 9362448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitivity to dexamethasone and absence of bcl-2 protein in Burkitt's lymphoma cell line (Black93) derived from a patient with acute tumor lysis syndrome: comparative study with other BL and non-BL lines.
    Tani A; Tatsumi E; Nakamura F; Kumagai S; Kosaka Y; Sano K; Nakamura H; Amakawa R; Ohno H
    Leukemia; 1996 Oct; 10(10):1592-603. PubMed ID: 8847894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temporal ordering of caspase activation and substrate cleavage during antigen receptor-triggered apoptosis in Ramos-Burkitt lymphoma B cells.
    An S; Park IC; Rhee CH; Hong SI; Knox K
    Int J Oncol; 2003 Aug; 23(2):257-68. PubMed ID: 12851674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. G2 cell cycle arrest and apoptosis are induced in Burkitt's lymphoma cells by the anticancer agent oracin.
    Klucar J; Al-Rubeai M
    FEBS Lett; 1997 Jan; 400(1):127-30. PubMed ID: 9000527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Wild-type p53 induces apoptosis in a Burkitt lymphoma (BL) line that carries mutant p53.
    Ramqvist T; Magnusson KP; Wang Y; Szekely L; Klein G; Wiman KG
    Oncogene; 1993 Jun; 8(6):1495-500. PubMed ID: 8502475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants.
    Hemann MT; Bric A; Teruya-Feldstein J; Herbst A; Nilsson JA; Cordon-Cardo C; Cleveland JL; Tansey WP; Lowe SW
    Nature; 2005 Aug; 436(7052):807-11. PubMed ID: 16094360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon-alpha-induced apoptosis in U266 cells is associated with activation of the proapoptotic Bcl-2 family members Bak and Bax.
    Panaretakis T; Pokrovskaja K; Shoshan MC; Grandér D
    Oncogene; 2003 Jul; 22(29):4543-56. PubMed ID: 12881711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apoptosis resistance, mitotic catastrophe, and loss of ploidy control in Burkitt lymphoma.
    Chumduri C; Gillissen B; Richter A; Richter A; Milojkovic A; Overkamp T; Müller A; Pott C; Daniel PT
    J Mol Med (Berl); 2015 May; 93(5):559-72. PubMed ID: 25548804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiproliferative function of p27kip1 is frequently inhibited in highly malignant Burkitt's lymphoma cells.
    Barnouin K; Fredersdorf S; Eddaoudi A; Mittnacht S; Pan LX; Du MQ; Lu X
    Oncogene; 1999 Nov; 18(46):6388-97. PubMed ID: 10597239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The cellular apoptosis of murine BW5147 thymoma during cold shock].
    Kruman II; Petruniaka VV; Beletskiĭ IP
    Tsitologiia; 1992; 34(2):54-61. PubMed ID: 1641907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of Bcl-2 overexpression on the ceramide pathway in daunorubicin-induced apoptosis of leukemic cells.
    Allouche M; Bettaieb A; Vindis C; Rousse A; Grignon C; Laurent G
    Oncogene; 1997 Apr; 14(15):1837-45. PubMed ID: 9150390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways.
    Fisher TC; Milner AE; Gregory CD; Jackman AL; Aherne GW; Hartley JA; Dive C; Hickman JA
    Cancer Res; 1993 Jul; 53(14):3321-6. PubMed ID: 8324744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inactivation of the ARF-MDM-2-p53 pathway in sporadic Burkitt's lymphoma in children.
    Wilda M; Bruch J; Harder L; Rawer D; Reiter A; Borkhardt A; Woessmann W
    Leukemia; 2004 Mar; 18(3):584-8. PubMed ID: 14712292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subcellular localization of PUMA regulates its pro-apoptotic activity in Burkitt's lymphoma B cells.
    Ambroise G; Portier A; Roders N; Arnoult D; Vazquez A
    Oncotarget; 2015 Nov; 6(35):38181-94. PubMed ID: 26431330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.